Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Caryn Upton"'
Autor:
Anne-Marie Demers, Soyeon Kim, Sara McCallum, Kathleen Eisenach, Michael Hughes, Linda Naini, Alberto Mendoza-Ticona, Neeta Pradhan, Kim Narunsky, Selvamuthu Poongulali, Sharlaa Badal-Faesen, Caryn Upton, Elizabeth Smith, N. Sarita Shah, Gavin Churchyard, Amita Gupta, Anneke Hesseling, Susan Swindells, for the ACTG A5300/IMPAACT I2003 PHOENIx Feasibility study team
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Drug susceptibility testing (DST) patterns of Mycobacterium tuberculosis (MTB) from patients with rifampicin-resistant tuberculosis (RR-TB) or multidrug-resistant TB (MDR-TB; or resistant to rifampicin and isoniazid (INH)), are im
Externí odkaz:
https://doaj.org/article/fc245c98756940ee99bd85cedb666055
Autor:
Soyeon, Kim, Xingye, Wu, Michael D, Hughes, Caryn, Upton, Kim, Narunsky, Alberto, Mendoza-Ticona, Saltnat, Khajenoori, Pedro, Gonzales, Sharlaa, Badal-Faesen, Justin, Shenje, Ayotunde, Omoz-Oarhe, Vanessa, Rouzier, Anthony J, Garcia-Prats, Anne-Marie, Demers, Linda, Naini, Elizabeth, Smith, Gavin, Churchyard, Susan, Swindells, N Sarita, Shah, Amita, Gupta, Anneke C, Hesseling
Publikováno v:
Pediatr Infect Dis J
BACKGROUND: Household contact investigation is an important strategy to identify individuals with tuberculosis (TB) exposure, infection, and disease, including those who may benefit from tuberculosis preventive therapy (TPT). Data in children exposed
Autor:
Susan Swindells, Rachel Mahachi, Florian von Groote-Bidlingmaier, Caryn Upton, William Murtaugh, Richard Hafner, Laura Moran, Xin Sun, Sachiko Miyahara, Solomon P. le Roux, Susan L. Rosenkranz, Andreas H. Diacon, Kathleen Donahue, Naadira Vanker, Kelly E. Dooley, Akbar Shahkolahi, Ronald Ssenyonga, Lynette Purdue, Eric L. Nuermberger, Mark Lojacono, Rachel Issa, Elisa H. Ignatius, Christopher Lane
Publikováno v:
Am J Respir Crit Care Med
Rationale: High-dose isoniazid is recommended in short-course regimens for multidrug-resistant tuberculosis (TB). The optimal dose of isoniazid and its individual contribution to efficacy against TB strains with inhA or katG mutations are unknown. Ob
Autor:
Yoninah S Cramer, William Murtaugh, Mats O. Karlsson, Justin Shenje, Richard Hafner, Jorge M. de los Rios, Kyla Comins, Barbara Rolls, Joan Gottesman, Francesca Conradie, Javier R. Lama, Jacob Tenai, Gary Maartens, Oladapo Alli, Lynnett Stone, Maria Guevara, Andreas H. Diacon, Florian von Groote-Bidlingmaier, Joel Morganroth, Caryn Upton, Laura Hovind, Kelly E. Dooley, Akbar Shahkolahi, Jennifer McClaren, Helen McIlleron, Gerald Tegha, Chanelle Wimbish, Susan L. Rosenkranz, Chris Hikuam, Laura Moran, Kathleen Donahue
Publikováno v:
The Lancet. Infectious diseases. 21(7)
Summary Background Bedaquiline and delamanid are the first drugs of new classes registered for tuberculosis treatment in 40 years. Each can prolong the QTc interval, with maximum effects occurring weeks after drug initiation. The cardiac safety and m
Publikováno v:
BMJ Case Reports. 14:e245612
Drug-resistant tuberculosis (DR-TB) continues to pose a threat to the global eradication of TB. Regimens for extensively drug-resistant (XDR) TB are lengthy and poorly tolerated, often with unsuccessful outcomes. The TB Alliance Nix-TB trial investig